Skip to content
  • Home
  • Company
    • About Us
    • Departments
    • Message From MD
  • Product
    • General
    • Hormones
    • Urology
    • Steroids
  • Media
    • Insights
    • Blogs
    • Gallery
  • Careers
  • Contact Us
Menu
Home / General / Anti-Vertigo / VERTIN
Anti-Vertigo

VERTIN

Betahistine is an antivertigo drug first used for treating vertigo associated with Meniere’s disease. It is also commonly used for patients with balance disorders.

QR Code

General Info

Generic Name:

Betahistine HCl

Therapeutic Category:

Anti-vertigo

Pharmacological Class:

Histamine

Composition:

Vertin 8

Each film coated tablet contains Betahistine HCl USP 8 mg

Vertin 16

Each film coated tablet contains Betahistine HCl USP 16 mg

Pregnancy Category:

B

Presentation:

Available in the pack size as 10 tablets X 10 strips

Mechanism of Action:

Betahistine predominantly interacts with histaminergic receptors. Betahistine has a very strong affinity as an antagonist for histamine H3 receptors and a weak affinity as an agonist for histamine H1 receptors.

  • H1 receptor agonist would give rise to local vasodilation and increased permeability. which helps to reverse the underlying problem of endolymphatic hydrops. Betahistine seems to dilate the blood vessels within the inner ear which can relieve pressure from excess fluid.
  • Betahistine blocks H3 receptors and releases neurotransmitters (histamine, norepinephrine, Ach, GABA). The increased amounts of histamine released from histaminergic nerve endings can stimulate histamine receptors. This stimulation explains the potent vasodilatory effects of betahistine in the inner ear.
Indications:
  • Meniere’s Disease (Vertigo, Dizziness, Tinnitus)
  • Central Vestibular Disorder
  • Cochlear disease
Dosage:

Route of administration: Oral

  • Initially, 8-16 mg 3 times daily (TID), preferably with food.
  • Maintenance dose 24-48 mg daily
  • For acute attacks, treatments include 8-16mg up to TDS
  • Preventive measures for recurrent attacks include:

16mg regularly TDS seems most effective in Meniere’s disease

Not recommended for children

Pharmacokinetics:

Absorption: Rapidly absorbed from the gastrointestinal tract.

Protein binding: Very low

Metabolism: Hepatic

Route of elimination: Renal

Half-life: 3.5 hours

Adverse Effects:
  • Headache
  • Low level of gastric side effects
  • Nausea can be a side effect, but the patient is generally already experiencing nausea due to the vertigo so it goes largely unnoticed.
  • Patients taking Vertin may experience several hypersensitivity and allergic reactions
Contraindications:

VERTIN is contraindicated in the following populations and situations:

  • Hypersensitivity to betahistine or any component of the formulation
  • Pheochromocytoma*
  • Peptic Ulcer Disease
Precautions:
  • People with Bronchial asthma.
Drug Interactions:
  • Enhance hypotensive effect of Tamsulosin when given with antihypertensive drugs (e.g. ACE inhibitors, B-Blockers, Calcium channel blocker etc.), adrenergic neuron blocker, alcohol, alpha blockers, Angiotensin-II receptor antagonist, antipsychotic, anxiolytic and hypnotic drugs.
Terminologies:

Pheochromocytoma: A tumor of the adrenal glands.

Related Products

RENOV
  • GERD & acid reflux
  • Erosive esophagitis
  • Peptic ulcer disease
  • H. pylori (combination therapy)
  • Acid-related disorders

General

RENOV

OMFLAM
  • Headache & migraine
  • Dental & musculoskeletal pain
  • Menstrual cramps
  • Postoperative pain
  • Fever & inflammation

General

OMFLAM

SIDAZE
  • Post-operative & traumatic inflammation
  • ENT inflammation (sinusitis)
  • Gynecological swelling (breast engorgement)
  • Urological inflammation (cystitis, epididymitis)
  • Dental & oral infections (pericoronitis, abscess) ury.

General

SIDAZE

EVALAX
  • Constipation
  • Hepatic encephalopathy
  • Ammonia detoxification support
  • Liver failure management
  • Adjunct in protein-restricted diets

General

EVALAX

OHM Insights

View Detail

OHM INSIGHT 24th issue

View Detail

OHM INSIGHT 23nd Issue

View Detail

OHM INSIGHTS- 22th Issue

View Detail

OHM INSIGHT 21st ISSUE

OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients.

Quick Links
  • About Us
  • Contact Us
  • Products
  • Dealer Locator
  • Blogs
  • Our Team
  • Career
Product Category
  • General
  • Urology
  • Steroids
  • Hormones
Corporate Office
(+977) 4110791, 01-4110761
info@opl.com.np
Babu Ram Acharya Marg, Sinamangal, Kathmandu
Factory Office
(+977) 4110791, 01-4110761
info@opl.com.np
Tathali-09, Bhaktapur

Copyright 2026 OHM Pharmaceuticals Lab Pvt. Ltd. All Rights Reserved

Website Designed & Developed by Theme Nepal